Search Results - "Widemann, A."

Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study by Widemann, A., Pasero, C., Arnaud, L., Poullin, P., Loundou, A. D., Choukroun, G., Sanderson, F., Lacroix, R., Sabatier, F., Coppo, P., Dignat‐George, F., Kaplanski, G.

“…Summary Background Autoimmune thrombotic thrombocytopenic purpura (AI‐TTP) is characterized by an excess of circulating ultralarge von Willebrand factor (VWF)…”
Get full text

Impact of Immunosuppressive Treatment on Endothelial Biomarkers After Kidney Transplantation by Al‐Massarani, G., Vacher‐Coponat, H., Paul, P., Widemann, A., Arnaud, L., Loundou, A., Robert, S., Berland, Y., Dignat‐George, F., Camoin‐Jau, L.

“…Endothelial dysfunction occurs in hemodialysis and kidney‐transplanted patients and can be enhanced by immunosuppressive therapy. Circulating endothelial cells…”
Get full text

CD146‐based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells by WIDEMANN, A., SABATIER, F., ARNAUD, L., BONELLO, L., AL‐MASSARANI, G., PAGANELLI, F., PONCELET, P., DIGNAT‐GEORGE, F.

“…Background: Circulating endothelial cells (CECs) have emerged as non‐invasive biomarkers of vascular dysfunction. The most widely used method for their…”
Get full text

Phase I Study of IPH4102, Anti‐KIR3DL2 Mab, in Relapsed/Refractory Cutaneous T‐Cell Lymphomas (CTCL): Dose‐escalation Safety, Biomarker and Clinical Activity Results by Bagot, M., Porcu, P., Ram‐Wolff, C., Khodadoust, M., Basem, W., Battistella, M., Marie‐Cardine, A., Vermeer, M., Mathieu, S., Whittaker, S., Duvic, M., Bensussan, A., Paturel, C., Bonnafous, C., Thonnart, N., Widemann, A., Bonin, C., Sicard, H., Paiva, C., Pilz, K., Kim, Y.H.

Get full text

Facteurs impliqués dans l’activation endothéliale au cours du purpura thrombotique thrombocytopénique by Tellier, E., Widemann, A., Brun, M., Sanderson, F., Poullin, P., Coppo, P., Dignat-George, F., Kaplanski, G.

“…Le purpura thrombotique thrombocytopénique acquis (PTT-a), est une microangiopathie thrombotique sévère d’origine auto-immune liée à la présence d’anticorps…”
Get full text

Rôle de la blessure calcique et des immunoglobulines G circulantes dans la mort cellulaire et la microvésiculation endothéliale au cours du purpura thrombotique thrombocytopénique auto-immun de l’adulte by Brun, M., Widemann, A., Bachelier, R., Robert, S., Poullin, P., Dignat-George, F., Kaplanski, G.

Get full text

Étude de la vasculocompétence endothéliale au cours du purpura thrombotique thrombocytopénique auto-immun de l’adulte : résultats préliminaires du PHRC National ENDO13 by Widemann, A., Pasero, C., Arnaud, L., Lacroix, R., Sabatier, F., Poullin, P., Dignat-George, F., Kaplanski, G.

Get full text

L’activation endothéliale dépendante du calcium, un catalyseur du purpura thrombotique thrombocytopénique auto-immun de l’adulte by Widemann, A., Robert, S., Robert, P., Salers, P., Farnarier, C., Poullin, P., Lefèvre, P., Dignat-Georges, F., Kaplanski, G.

Get full text

Dysfonction endothéliale et vasculo-compétence au cours des micro-angiopathies thrombotiques by Widemann, A., Brun, M., Poullin, P., Dignat-George, F., Kaplanski, G.

Get full text

Knowledge of the man and occupational selection based on handwriting by Widemann, A

Get more information